The cAMP-PKA pathways regulate the activity and expression of the cAMP-response element modulator (CREM) protein family in CD4+ T-cells, linked to effector cytokine expression in psoriasis/PsA and other autoimmune diseases, such as SLE
Control Release 323, 203224
Water, Butylene Glycol, Niacinamide, 1,2-Hexanediol, Zea Mays (Corn) Starch, Chondrus Crispus Extract, Chlorella Vulgaris Extract, Saccharum Officinarum (Sugarcane) Extract, Centella Asiatica Leaf Extract, Chitosan, Malus Domestica Fruit Cell Culture Extract, Polyacrylate Crosspolymer-6, Betaine, Glucose, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Tromethamine, Acetyl Glucosamine, Fructooligosaccharides, Fructose, Glycerin, Pentylene Glycol, Ethylhexylglycerin, Allantoin, Dipropylene Glycol, Adenosine, Glutathione, Madecassoside, Hydroxypropyl Methylcellulose, Hydrogenated Lecithin, Beta-Glucan, Cholesterol, Asiaticoside, Ascorbic Acid, 3-O-Ethyl Ascorbic Acid, Ascorbyl Glucoside, Ceramide NP, Tocopherol, Ferulic Acid, Lactic Acid, Disodium EDTA, Carbomer, Iron Oxides (CI 77491)
National use of postmenopausal hormone therapy: annual trends and response to recent evidence
Phthalates have endocrine-disrupting properties and are harmful to human health [433]
Native GLP-1 provides transient, meal-related metabolic effects lasting minutes, contributing to normal postprandial glucose regulation but offering no sustained therapeutic impact